Milestone Scientific Inc
NYSE American:MLSS

  • LAST PRICE
    0.7910
  • TODAY'S CHANGE (%)
    0.0170 (2.1964%)
  • Bid / Lots
    0.8000/ 2
  • Ask / Lots
    0.8700/ 5
  • Open / Previous Close
    0.7700 / 0.7740
  • Day Range
    0.7695
    0.8391
  • 52 Week Range
    0.5200
    1.1000
  • Volume
    226,705

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 20, 2024

  • Nov 14, 2024

      Show headlines and story abstract

    • 5:52PM ET on Thursday Nov 14, 2024 by Dow Jones
      Companies Mentioned: MLSS

      By Kailyn Rhone

      Milestone Scientific named Chairman Neal Goldman as interim chief executive officer following the retirement of its current CEO Arjan Haverhals.

    • 5:50PM ET on Thursday Nov 14, 2024 by MT Newswires
      Companies Mentioned: MLSS
      05:50 PM EST, 11/14/2024 (MT Newswires) -- Milestone Scientific (MLSS) said Thursday that Chief Executive Arjan Haverhals will retire on Dec. 31. Chairman of the board Neal Goldman was appointed as interim CEO, effective Haverhals' retirement, accor...

    • 4:30PM ET on Thursday Nov 14, 2024 by Dow Jones
      Companies Mentioned: MLSS

      (tables follow)
      MILESTONE SCIENTIFIC AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) September 30, 2024 December 31, 2023 ASSETS (Unaudited) Current assets: Cash and cash equivalents $ 4,775,597 $ 2,977,713 Marketable securities - 2,976,573 Accounts receivable, net of allowance for credit losses of $10,000, respectively 550,969 312,664 Accounts receivable, related party net 3,013 - Prepaid expenses and other current assets 646,130 517,785 Inventories 3,711,636 2,638,186 Advances on contracts 1,011,306 1,371,548 ---------------- --------------- Total current assets 10,698,651 10,794,469 Furniture, fixtures and equipment, net 11,265 10,024 Intangibles, net 155,255 178,636 Right of use assets finance lease 2,511 8,998 Right of use assets operating lease 283,086 355,235 Other assets 24,150 24,150 ---------------- --------------- Total assets $ 11,174,918 $ 11,371,512 ================ =============== LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 1,138,060 $ 689,604 Accounts payable, related party 740,017 410,512 Accrued expenses and other payables 1,267,718 1,511,717 Accrued expenses, related party 281,947 137,189 Accrued liabilities noncontrolling interest 214,000 214,000 Current portion of finance lease liabilities 3,088 10,264 Current portion of operating lease liabilities 112,955 103,427 ---------------- --------------- Total current liabilities 3,757,785 3,076,713 Non-current portion of finance lease liabilities - 434 Non-current portion of operating lease liabilities 195,649 281,853 ---------------- --------------- Total liabilities $ 3,953,434 $ 3,359,000 Commitments and contingencies Stockholders' equity Common stock, par value $0.001; authorized 100,000,000 shares; 77,709,455 shares issued and 77,676,122 shares outstanding as of September 30, 2024; 75,881,840 shares issued and 75,848,507 shares outstanding as of December 31, 2023; 77,710 75,881 Additional paid in capital 134,072,861 132,187,656 Accumulated deficit (126,017,571) (123,339,509) Treasury stock, at cost, 33,333 shares (911,516) (911,516) ---------------- --------------- Total Milestone Scientific, Inc. stockholders' equity 7,221,484 8,012,512 Total liabilities and stockholders' equity $ 11,174,918 $ 11,371,512 ================ =============== MILESTONE SCIENTIFIC AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) For the For the three three For the For the months months nine months nine months ended ended ended ended September September September September 30, 2024 30, 2023 30, 2024 30, 2023 Product sales, net $ 2,513,805 $ 2,059,284 $ 6,616,414 $ 7,566,848 Cost of products sold 677,585 555,850 1,692,888 2,284,730 ---------- ---------- ---------- ---------- Gross profit 1,836,220 1,503,434 4,923,526 5,282,118 Selling, general and administrative expenses 3,064,769 2,823,765 8,968,226 9,834,781 Research and development expenses 232,056 170,478 641,235 524,472 Depreciation and amortization expense 8,574 15,896 28,735 49,798 ---------- ---------- ---------- ---------- Total operating expenses 3,305,399 3,010,139 9,638,196 10,409,051 Loss from operations (1,469,179) (1,506,705) (4,714,670) (5,126,933) Interest income 8,008 30,600 53,513 102,669 Gain on sale of net operating losses - - 1,983,095 - ---------- ---------- ---------- ---------- Loss before provision for income taxes (1,461,171) (1,476,105) (2,678,062) (5,024,264) Net loss (1,461,171) (1,476,105) (2,678,062) (5,024,264) Net loss attributable to noncontrolling interests $ - $ (9,811) $ - $ (33,987) ---------- ---------- ---------- ---------- Net loss attributable to Milestone Scientific Inc. $(1,461,171) $(1,466,294) $(2,678,062) $(4,990,277) ========== ========== ========== ========== Net loss per share applicable to common stockholders-- Basic and Diluted (0.02) (0.02) (0.03) (0.07) Weighted average shares outstanding and to be issued-- Basic and diluted 79,966,833 73,730,921 80,165,181 72,374,693

Peers Headlines